Price target upside
Myriad Genetics Price Target: +23.6% vs Current Price
MYGN target gap is +23.6% from $3.20 to $3.96. As of 2026-08-22.
Direct answer
Myriad Genetics's analyst target implies +23.6%.
The average target is $3.96 compared with a recorded current price of $3.20.
This percentage is calculated from the verified average target and recorded market price.
Forecast evidence checked August 22, 2026.
Get free Myriad Genetics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $3.20
- Average price target
- $3.96
- High price target
- $5.45
- Low price target
- $3.00
- Low target gap
- -6.3%
- Target upside
- +23.6%
- High target gap
- +70.3%
- Target range width
- 76.6%
- Consensus rating
- Hold
- Analysts
- 8
- Evidence date
- August 22, 2026
- Valid through
- August 29, 2026
Explore related company data
Read the frequently asked questions.
How much upside or downside does Myriad Genetics's average target imply?
Myriad Genetics's average target is $3.96 versus a recorded price of $3.20. The difference is +23.6%.
How far are Myriad Genetics's low and high targets from the recorded price?
The low target implies -6.3%, while the high target implies +70.3%.
How many analysts are included in Myriad Genetics's consensus?
The verified consensus includes 8 analysts.
How is Myriad Genetics's target upside or downside calculated?
The average target of $3.96 is divided by the recorded price of $3.20, then one is subtracted to produce +23.6%. This does not guarantee a future return.
When was Myriad Genetics's analyst forecast verified?
The data was verified on 2026-08-22. The dataset is valid through 2026-08-29.